A miRNA composition for predicting chronic hepatitis B inflammatory damage
A technology for chronic hepatitis B and inflammation, applied in the field of medical testing, can solve problems such as unacceptable by patients, and achieve the effect of improving accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Example 1 Screening of chronic hepatitis B inflammatory injury-related miRNA
[0028] Using a four-step screening method:
[0029] (1) In the discovery stage, we used the next-generation deep sequencing technology (IlluminaHiseq 2000) to detect the mixed samples of the discovery set, found miRNAs with differential expression, and selected 6 cases with mild and moderate inflammation and necrosis respectively;
[0030] (2) In the screening stage, use qRT-PCR method to select internal reference miRNA, establish a uniform small number of cohort screening sets, measure the cycle number (Ct) by 2-△△Ct, and eliminate miRNACt value75%; For miRNAs with p<0.05, 20 cases were selected for mild and moderate inflammation and necrosis respectively;
[0031] (3) In the training stage, the target miRNAs selected in the training and screening stage were tested by using qRT-PCR on a large sample training set (136 cases of mild and 201 cases of moderate inflammation and necrosis respecti...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



